Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.14M | $9.85M | -88.48% |
Operating Income | $-66.99M | $-50.96M | -31.46% |
Net Income | $-61.95M | $-49.04M | -26.34% |
EPS (Basic) | $-0.76 | $-0.71 | -7.04% |
EPS (Diluted) | $-0.76 | $-0.71 | -7.04% |
R&D Expense | $48.79M | $37.8M | +29.05% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $440.35M | $464.11M | -5.12% |
Current Assets | $305.56M | $324.46M | -5.83% |
Total Liabilities | $145.95M | $146.63M | -0.47% |
Current Liabilities | $66.49M | $57.16M | +16.33% |
Stockholders' Equity | $294.4M | $317.47M | -7.27% |
Cash & Equivalents | $69.23M | $129.02M | -46.34% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-49.87M | $-35.77M | -39.43% |
Investing Cash Flow | $-4.75M | $23.27M | -120.39% |
Financing Cash Flow | $192,000 | $0 | — |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -5902.3% | -517.3% | -5384.97% |
Net Margin | -5458.1% | — | — |
ROE | -21.0% | — | — |
ROA | -14.1% | — | — |
Current Ratio | $4.596 | — | — |
Debt to Equity | $0.496 | — | — |
Other companies in Biotechnology